PH12020551635A1 - Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof - Google Patents

Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Info

Publication number
PH12020551635A1
PH12020551635A1 PH12020551635A PH12020551635A PH12020551635A1 PH 12020551635 A1 PH12020551635 A1 PH 12020551635A1 PH 12020551635 A PH12020551635 A PH 12020551635A PH 12020551635 A PH12020551635 A PH 12020551635A PH 12020551635 A1 PH12020551635 A1 PH 12020551635A1
Authority
PH
Philippines
Prior art keywords
pharmaceutically acceptable
acceptable salt
coated tablet
enteric coated
fenofibric acid
Prior art date
Application number
PH12020551635A
Other languages
English (en)
Inventor
Youn Woong Choi
Sang Min Cho
Do Hyoung Ki
In Ho Song
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of PH12020551635A1 publication Critical patent/PH12020551635A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH12020551635A 2018-04-24 2020-10-01 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof PH12020551635A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180047078A KR102081095B1 (ko) 2018-04-24 2018-04-24 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제
PCT/KR2019/004601 WO2019208967A1 (fr) 2018-04-24 2019-04-16 Comprimé à enrobage entérique comprenant de l'acide fénofibrique ou un sel pharmaceutiquement acceptable de celui-ci

Publications (1)

Publication Number Publication Date
PH12020551635A1 true PH12020551635A1 (en) 2021-07-26

Family

ID=68295511

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12020551635A PH12020551635A1 (en) 2018-04-24 2020-10-01 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Country Status (3)

Country Link
KR (1) KR102081095B1 (fr)
PH (1) PH12020551635A1 (fr)
WO (1) WO2019208967A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112603899A (zh) * 2020-12-23 2021-04-06 南京友杰医药科技有限公司 瑞巴派特肠溶片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
WO2006084475A2 (fr) * 2005-04-13 2006-08-17 Lifecycle Pharma A/S Comprimé comprenant un fibrate
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
KR101925590B1 (ko) * 2016-08-30 2018-12-05 대원제약 주식회사 개선된 생체이용률을 갖는 페노피브릭산 제제

Also Published As

Publication number Publication date
WO2019208967A1 (fr) 2019-10-31
KR102081095B1 (ko) 2020-02-25
KR20190123411A (ko) 2019-11-01

Similar Documents

Publication Publication Date Title
MX2020003629A (es) Produccion fermentativa de acido n-acetilneuraminico.
MX2020007554A (es) Formulacion farmaceutica que comprende esomeprazol y bicarbonato de sodio.
EP3378434A4 (fr) Procédé pour la fabrication d'une structure dentaire, structure dentaire obtenue et ensemble dentaire formé d'une structure vissée sur un implant dentaire
EP4076003A4 (fr) Procédé d'augmentation de la productivité d'un animal non ruminant
ZA202107709B (en) Cell-free production of ribonucleic acid
PH12018501356A1 (en) Cocrystal, production method tereof, and medicament containing cocrystal
EP4058371A4 (fr) Coque d'étiquetage pour flacon de médicament
MY189306A (en) Tablet
PH12020551635A1 (en) Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof
IN2013MU01985A (fr)
EP3885333A4 (fr) Procédé de fabrication de 1,2-difluoréthylène
EP3689349A4 (fr) Médicament contenant un composé d'acide pyridylaminoacétique
EP3728280C0 (fr) Procédé pour améliorer la biodisponibilité d'un médicament
EP4069214A4 (fr) Vecteurs de médicament à base de polyphosphazène
EP3962460A4 (fr) Procédé pour la production de gélules à base de pullulane
EP3642190A4 (fr) Procédé de fabrication d'esters de l'acide 2,5-furandicarboxylique
WO2020018053A3 (fr) Comprimé comprenant du dasatinib
WO2018229796A3 (fr) Procédé de préparation de chlorhydrate de betrixaban et de sel de maléate de betrixaban
UA124942C2 (uk) Спосіб одержання енантіомерів пірліндолу та їхніх солей
MX2017015888A (es) Preparacion de acido 2,5,6-trihidroxi-3-hexenoico y acido 2,5-dhidroxi-3-pentenoico y esteres de los mismos a partir de azucares c6 y c5.
GB201722224D0 (en) Aspirin drug intermediate high purity acetic acid production plant
AU2019904825A0 (en) Method of Increasing the Productivity of a Non-ruminant Animal
GB201919333D0 (en) Pharmaceutical manufacturing process support
EP3852720A4 (fr) Forme galénique comprenant une charpente de solution solide structurée de médicament modérément soluble et son procédé de fabrication
TR201819312A2 (tr) Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu